Next Article in Journal
Hypothalamic-Pituitary-Adrenal Axis Programming after Recurrent Hypoglycemia during Development
Next Article in Special Issue
MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH
Previous Article in Journal / Special Issue
MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment
Article Menu

Export Article

Open AccessArticle
J. Clin. Med. 2015, 4(9), 1713-1728; doi:10.3390/jcm4091713

MicroRNA-224 Induces G1/S Checkpoint Release in Liver Cancer

1
Department of Gastroenterology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China
2
Division of Gastroenterology and Hepatology, Department of Medicine, The Johns Hopkins Hospital, Baltimore, MD, 21205, USA
3
Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
4
The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Hospital, Baltimore, MD, 21287, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Rajagopal N. Aravalli
Received: 10 July 2015 / Revised: 3 August 2015 / Accepted: 12 August 2015 / Published: 26 August 2015
(This article belongs to the Special Issue MicroRNAs: Novel Biomarkers for Liver Diseases)
View Full-Text   |   Download PDF [695 KB, uploaded 26 August 2015]   |  

Abstract

Profound changes in microRNA (miR) expression levels are frequently found in liver cancers compared to the normal liver. In this study, we evaluate the expression of miR-224 in human HCC and CCA, as well as its downstream targets and affected pathways. We show that miR-224 is upregulated in a large cohort of human CCA, similar to its upregulation in human HCC. For the purpose of studying the roles of miR-224 in HCC and CCA, we enforced miR-224 expression in cells. mRNA arrays followed by Ingenuity Pathway Analysis (IPA)-identified putative molecules and pathways downstream of miR-224. Phenotypically, we report that enforced expression of miR-224 increases the growth rate of normal cholangiocytes, CCA cell lines, and HCC cell lines. In addition, we identified, in an unbiased fashion, that one of the major biologic processes affected by miR-224 is Gap1 (G1) to Synthesis (S) transition checkpoint release. We next identified p21, p15, and CCNE1 as downstream targets of miR-224 and confirmed the coordinated downregulation results in the increased phosphorylation of Retinoblastoma (Rb) with resulting G1/S checkpoint release. Our data suggest that miR-224 is a master regulator of cell cycle progression, and that its overexpression results in G1/S checkpoint release followed by accelerated cell growth. View Full-Text
Keywords: cholangiocarcinoma; miR-224; cell cycle cholangiocarcinoma; miR-224; cell cycle
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

An, F.; Olaru, A.V.; Mezey, E.; Xie, Q.; Li, L.; Piontek, K.B.; Selaru, F.M. MicroRNA-224 Induces G1/S Checkpoint Release in Liver Cancer. J. Clin. Med. 2015, 4, 1713-1728.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top